Genitourinary syndrome of menopause, a new term for a condition more renowned as
atrophic vaginitis, is a hypoestrogenic condition with external genital, urological, and sexual …

Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%–60% of
postmenopausal women who are suffering in silence from this condition. Hormonal …

Objective: The aim of the study was to evaluate efficacy of fractional CO 2 vaginal laser
treatment (Laser, L) and compare it to local estrogen therapy (Estriol, E) and the combination …

Objective: The aim of the study was to compare 6-month efficacy and safety for treatment of
vaginal dryness/genitourinary syndrome of menopause in women undergoing fractionated …

Introduction and hypothesis The terminology in current use for sexual function and
dysfunction in women with pelvic floor disorders lacks uniformity, which leads to uncertainty …

Objective Microablative fractional CO 2 laser has been proven to determine tissue
remodeling with neoformation of collagen and elastic fibers on atrophic skin. The aim of our …

Background Genitourinary syndrome of menopause (GSM) is a widespread condition with a
great impact on quality of life and self-image. Aim We aimed to systematically review the …

Laser therapy has a therapeutic role in various medical conditions and most recently has
gained interest as a non-hormonal treatment for genitourinary syndrome of menopause …

Objectives: To evaluate the long-term efficacy of a second generation of vaginal laser
treatment, the vaginal erbium laser, as a non-ablative photothermal therapy for the …

Objectives: The aim of the study was to assess the safety and efficacy of a novel fractional
CO 2 laser for the treatment of genitourinary syndrome of menopause (GSM). Methods …